| Biofilms and host response–helpful or harmful C Moser, HT Pedersen, CJ Lerche, M Kolpen, L Line, K Thomsen, ... APMIS 125 (4), 320-338, 2017 | 154 | 2017 |
| Antibiotic therapy as personalized medicine–general considerations and complicating factors C Moser, CJ Lerche, K Thomsen, T Hartvig, J Schierbeck, PØ Jensen, ... Apmis 127 (5), 361-371, 2019 | 69 | 2019 |
| Hyperbaric oxygen sensitizes anoxic Pseudomonas aeruginosa biofilm to ciprofloxacin M Kolpen, CJ Lerche, KN Kragh, T Sams, K Koren, AS Jensen, L Line, ... Antimicrobial Agents and Chemotherapy 61 (11), 10.1128/aac. 01024-17, 2017 | 55 | 2017 |
| Hyperbaric oxygen therapy augments tobramycin efficacy in experimental Staphylococcus aureus endocarditis CJ Lerche, LJ Christophersen, M Kolpen, PR Nielsen, H Trøstrup, ... International Journal of Antimicrobial Agents 50 (3), 406-412, 2017 | 52 | 2017 |
| Anti-biofilm approach in infective endocarditis exposes new treatment strategies for improved outcome CJ Lerche, F Schwartz, M Theut, EL Fosbøl, K Iversen, H Bundgaard, ... Frontiers in Cell and Developmental Biology 9, 643335, 2021 | 36 | 2021 |
| Lipocalin-2 Functions as Inhibitor of Innate Resistance to Mycobacterium tuberculosis SL Dahl, JS Woodworth, CJ Lerche, EP Cramer, PR Nielsen, C Moser, ... Frontiers in immunology 9, 2717, 2018 | 33 | 2018 |
| Chronic Pseudomonas aeruginosa biofilm infection impairs murine S100A8/A9 and neutrophil effector cytokines—implications for delayed wound closure? H Trøstrup, CJ Lerche, LJ Christophersen, K Thomsen, PØ Jensen, ... Pathogens and Disease 75 (7), ftx068, 2017 | 32 | 2017 |
| Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: Not just hot air PØ Jensen, SA Møller, CJ Lerche, C Moser, T Bjarnsholt, O Ciofu, ... Biofilm 1, 100008, 2019 | 31 | 2019 |
| Pseudomonas aeruginosa biofilm hampers murine central wound healing by suppression of vascular epithelial growth factor H Trøstrup, CJ Lerche, LJ Christophersen, K Thomsen, PØ Jensen, ... International wound journal 15 (1), 123-132, 2018 | 21 | 2018 |
| Adjunctive dabigatran therapy improves outcome of experimental left-sided Staphylococcus aureus endocarditis CJ Lerche, LJ Christophersen, JP Goetze, PR Nielsen, K Thomsen, ... PloS one 14 (4), e0215333, 2019 | 20 | 2019 |
| In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments L Christophersen, FA Schwartz, CJ Lerche, T Svanekjær, KN Kragh, ... Journal of Cystic Fibrosis 19 (6), 996-1003, 2020 | 17 | 2020 |
| Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremia WK Scott, FM Medie, F Ruffin, BK Sharma-Kuinkel, DD Cyr, S Guo, ... PLoS genetics 14 (10), e1007667, 2018 | 17 | 2018 |
| Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds H Trøstrup, CJ Lerche, L Christophersen, PØ Jensen, N Høiby, C Moser International Journal of Molecular Sciences 18 (7), 1359, 2017 | 14 | 2017 |
| Attainment of target antibiotic levels by oral treatment of left-sided infective endocarditis: a POET substudy M Bock, AM Theut, JGC Van Hasselt, H Wang, K Fuursted, N Høiby, ... Clinical Infectious Diseases 77 (2), 242-251, 2023 | 12 | 2023 |
| DANMAP 2020: Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark ASR Duarte, BB Høg, HB Korsgaard, M Attauabi, J Boel, T Dalby, ... Statens Serum Institut og Technical University of Denmark, 2021 | 12* | 2021 |
| Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model ASB Laulund, H Trøstrup, CJ Lerche, K Thomsen, L Christophersen, ... Pathogens and disease 78 (5), ftz027, 2020 | 12 | 2020 |
| Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model K Thomsen, L Christophersen, CJ Lerche, DB Holmgaard, H Calum, ... International Journal of Antimicrobial Agents 57 (1), 106213, 2021 | 11 | 2021 |
| Low efficacy of tobramycin in experimental Staphylococcus aureus endocarditis CJ Lerche, LJ Christophersen, H Trøstrup, K Thomsen, PØ Jensen, ... European Journal of Clinical Microbiology & Infectious Diseases 34, 2349-2357, 2015 | 11 | 2015 |
| Novel human in vitro vegetation simulation model for infective endocarditis FA Schwartz, L Christophersen, AS Laulund, R Lundquist, C Lerche, ... Apmis 129 (11), 653-662, 2021 | 10 | 2021 |
| Dynamics of a Staphylococcus aureus infective endocarditis simulation model FA Schwartz, L Nielsen, J Struve Andersen, M Bock, L Christophersen, ... APMIS 130 (8), 515-523, 2022 | 7 | 2022 |
Claus MoserRigshospitaletVerified email at dadlnet.dk
